Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 15

Results For "advisory"

165 News Found

World Health Organisation SAGE recommends use of Novavax Covid-19 vaccine as booster
News | December 22, 2021

World Health Organisation SAGE recommends use of Novavax Covid-19 vaccine as booster

SAGE recommends additional third dose of the vaccine administered to immunocompromised persons


New data suggests Covaxin generates robust memory to Covid-19 and variants six months after vaccination
Biotech | December 17, 2021

New data suggests Covaxin generates robust memory to Covid-19 and variants six months after vaccination

Effectiveness of Covaxin against the Omicron variant is currently being studied


Landbell and GreenForest solutions announce JV to reduce plastic waste
Sustainability | December 13, 2021

Landbell and GreenForest solutions announce JV to reduce plastic waste

The company will provide recyclability services to brands with a final goal to help them move to fully recyclable packaging


Molnupiravir, a step closer to approval in the fight against Covid-19
News | December 02, 2021

Molnupiravir, a step closer to approval in the fight against Covid-19

The U.S. FDA advisory committee voted 13-10 in favour of the oral antiviral medicine


Serum seeks DCGI approval for booster dose in India
News | December 02, 2021

Serum seeks DCGI approval for booster dose in India

The UK’s Medicine and Healthcare products Regulatory Agency has already approved the booster dose of AstraZenenca’s Covid-19 vaccine, which is administered in India


Sygnature Discovery appoints Louisa Jordison as Chief Financial Officer
Appointment | December 01, 2021

Sygnature Discovery appoints Louisa Jordison as Chief Financial Officer

She replaces Victoria Tabiner, who is stepping down after 10 years at Sygnature


Merck and Ridgeback Biotherapeutics Covid-19 pill less effective
Biotech | November 28, 2021

Merck and Ridgeback Biotherapeutics Covid-19 pill less effective

Merck has shared these additional analyses with the FDA and they will be presented to the FDA’s Antimicrobial Drugs Advisory Committee on Nov. 30th


Vital Strategies India appoints L. M. Singh as MD, India and Global Head, Partnerships and Innovative Finance
People | November 24, 2021

Vital Strategies India appoints L. M. Singh as MD, India and Global Head, Partnerships and Innovative Finance

In his new role as Managing Director India and Global Head, Partnerships and Innovative Finance, Singh will oversee the financial, human, and operational functions of the India office


Laurus Labs acquires stake in IIT Bombay incubated ImmunoACT
News | November 20, 2021

Laurus Labs acquires stake in IIT Bombay incubated ImmunoACT

ImmunoACT has a portfolio of CAR-T therapy assets under various development stages for the treatment of multiple autoimmune diseases and oncology indications.


Sanofi to invest up to US $ 60 million in Gyroscope
Startup | November 09, 2021

Sanofi to invest up to US $ 60 million in Gyroscope

A Sanofi R&D executive will join the Gyroscope Clinical Advisory Board to advise on matters related to the development of GT005 for geographic atrophy (GA).